Absci (ABSI) Metrics: History & Chart

Absci Corporation(ABSI)

Biotechnology · Vancouver, WA

$10.27-1.26 (-10.93%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Absci Corporation

Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.

Vancouver, WA

140 employees

www.absci.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Sean McClain

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+21.50%
30D Total Return	+30.73%
YTD Total Return	+230.37%
1Y Total Return	+241.12%
3Y Total Return	+741.67%
5Y Total Return	+4.53%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+230.37%
2025	+33.21%
2024	-37.62%
2023	+100.00%
2022	-74.39%
2021	N/A

CAGR TTM	+239.13%
CAGR 3Y	+103.38%
CAGR 5Y	+0.89%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

ABSI Valuation Metrics

ABSI Stock Price Metrics

ABSI Dividend Metrics

ABSI Growth Rate Metrics

ABSI Discounted Cash Flow Metrics

ABSI Returns By Period

ABSI Yearly Returns

ABSI Average Annual Returns By Period (CAGR)

ABSI Revenue Metrics

ABSI PE Ratio Metrics

ABSI PS Ratio Metrics

ABSI PB Ratio Metrics

ABSI Price to Free Cash Flow Ratio Metrics

ABSI Debt to Equity Ratio Metrics

ABSI PEG Ratio Metrics

ABSI FCF Yield

ABSI Earnings Yield

ABSI EBITDA Yield

ABSI OCF Yield

ABSI EV/EBIT Ratio Metrics

ABSI EV/EBITDA Ratio Metrics

ABSI EV/Assets Ratio Metrics

ABSI EV/Sales Ratio Metrics

ABSI Current Ratio Metrics

ABSI Quick Ratio Metrics

ABSI ROIC Metrics

ABSI Return on Assets Metrics

ABSI Return on Equity Metrics

ABSI Net Profit Margin Metrics

ABSI Gross Profit Margin Metrics

ABSI Tax Rate Metrics

PS Ratio	1163.13
PS Ratio Avg TTM	406.59
PS Ratio Avg 3Y	95.02
Current VS TTM Avg	+186.07%
Current VS 3Y Avg	+1124.15%
Current VS 5Y Avg	+1314.51%

PB Ratio	7.38
PB Ratio Avg TTM	4.16
PB Ratio Avg 3Y	1.97
Current VS TTM Avg	+77.48%
Current VS 3Y Avg	+274.34%
Current VS 5Y Avg	+369.11%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	0.03
Debt/Equity Ratio Avg 3Y	0.05
Current VS TTM Avg	-46.97%
Current VS 3Y Avg	-71.93%
Current VS 5Y Avg	-75.11%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	6.36
Ev/Assets Ratio Avg TTM	3.56
Ev/Assets Ratio Avg 3Y	1.58
Current VS TTM Avg	+78.60%
Current VS 3Y Avg	+302.29%
Current VS 5Y Avg	+471.00%

Ev/Sales Ratio	1096.39
Ev/Sales Ratio Avg TTM	394.01
Ev/Sales Ratio Avg 3Y	88.54
Current VS TTM Avg	+178.27%
Current VS 3Y Avg	+1138.27%
Current VS 5Y Avg	+1531.01%

Current Ratio	10.63
Current Ratio Avg TTM	6.81
Current Ratio Avg 3Y	5.65
Current VS TTM Avg	+55.99%
Current VS 3Y Avg	+88.01%
Current VS 5Y Avg	+76.86%

Quick Ratio	10.63
Quick Ratio Avg TTM	6.81
Quick Ratio Avg 3Y	5.60
Current VS TTM Avg	+55.99%
Current VS 3Y Avg	+89.61%
Current VS 5Y Avg	+79.15%

ROIC	(52.66%)
ROIC Avg 3Y	(55.51%)
ROIC Avg 5Y	(44.55%)
Current VS 3Y Avg	+5.13%
Current VS 5Y Avg	-18.22%
Current VS 10Y Avg	-25.82%

ROA	(45.02%)
ROA Avg TTM	(13.49%)
ROA Avg 3Y	(12.17%)
Current VS TTM Avg	-233.82%
Current VS 3Y Avg	-269.95%
Current VS 5Y Avg	-324.58%

ROE	(49.19%)
ROE Avg TTM	(59.74%)
ROE Avg 3Y	(54.99%)
Current VS TTM Avg	+17.66%
Current VS 3Y Avg	+10.54%
Current VS 5Y Avg	-3.89%

Net Profit Margin	(7756.37%)
Net Profit Margin Avg TTM	(8301.51%)
Net Profit Margin Avg 3Y	(5020.53%)
Current VS TTM Avg	+6.57%
Current VS 3Y Avg	-54.49%
Current VS 5Y Avg	-142.83%

Gross Profit Margin	(319.36%)
Gross Pft Margin Avg TTM	(930.77%)
Gross Pft Margin Avg 3Y	(831.67%)
Current VS TTM Avg	+65.69%
Current VS 3Y Avg	+61.60%
Current VS 5Y Avg	+52.81%

Tax Rate	(0.06%)
Tax Rate Avg 3Y	0.05%
Tax Rate Avg 5Y	1.39%
Current VS 3Y Avg	-209.09%
Current VS 5Y Avg	-104.33%
Current VS 10Y Avg	-105.05%